Alliancebernstein L.P. Legend Biotech Corp Transaction History

Alliancebernstein L.P.

  • $280 Billion
  • Q4 2024

A detailed history of Alliancebernstein L.P. transactions in Legend Biotech Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,476,151 shares of LEGN stock, worth $54.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,476,151
Previous 1,311,733 12.53%
Holding current value
$54.5 Million
Previous $63.9 Million 24.85%
% of portfolio
0.02%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$32.49 - $50.28 $5.34 Million - $8.27 Million
164,418 Added 12.53%
1,476,151 $48 Million
Q3 2024

Nov 14, 2024
BUY
$43.55 - $59.88 $9.75 Million - $13.4 Million
223,884 Added 20.58%
1,311,733 $63.9 Million
Q2 2024

Aug 14, 2024
SELL
$39.5 - $57.22 $999,705 - $1.45 Million
-25,309 Reduced 2.27%
1,087,849 $48.2 Million
Q1 2024

May 14, 2024
SELL
$55.06 - $69.99 $4.01 Million - $5.1 Million
-72,799 Reduced 6.14%
1,113,158 $62.4 Million
Q4 2023

Feb 14, 2024
BUY
$57.25 - $69.74 $4.81 Million - $5.86 Million
84,076 Added 7.63%
1,185,957 $71.4 Million
Q3 2023

Nov 14, 2023
SELL
$63.16 - $76.5 $21.4 Million - $25.9 Million
-339,011 Reduced 23.53%
1,101,881 $74 Million
Q2 2023

Aug 15, 2023
SELL
$46.28 - $75.01 $6.34 Million - $10.3 Million
-137,055 Reduced 8.69%
1,440,892 $99.5 Million
Q1 2023

May 15, 2023
BUY
$43.42 - $57.37 $12.4 Million - $16.4 Million
286,249 Added 22.16%
1,577,947 $76.1 Million
Q4 2022

Feb 14, 2023
SELL
$38.8 - $55.46 $9.49 Million - $13.6 Million
-244,573 Reduced 15.92%
1,291,698 $64.5 Million
Q3 2022

Nov 15, 2022
BUY
$38.15 - $57.1 $2.7 Million - $4.03 Million
70,651 Added 4.82%
1,536,271 $62.7 Million
Q2 2022

Aug 15, 2022
SELL
$33.54 - $55.0 $20.6 Million - $33.7 Million
-613,155 Reduced 29.5%
1,465,620 $80.6 Million
Q1 2022

May 13, 2022
BUY
$31.02 - $48.18 $1.59 Million - $2.47 Million
51,176 Added 2.52%
2,078,775 $75.5 Million
Q4 2021

Feb 14, 2022
BUY
$41.14 - $56.98 $1.21 Million - $1.68 Million
29,449 Added 1.47%
2,027,599 $94.5 Million
Q3 2021

Nov 10, 2021
BUY
$35.31 - $50.56 $3.57 Million - $5.12 Million
101,167 Added 5.33%
1,998,150 $101 Million
Q2 2021

Jul 30, 2021
SELL
$25.8 - $41.09 $5.76 Million - $9.18 Million
-223,308 Reduced 10.53%
1,896,983 $77.9 Million
Q1 2021

May 06, 2021
BUY
$23.55 - $32.4 $21 Million - $28.9 Million
890,832 Added 72.46%
2,120,291 $61.5 Million
Q4 2020

Feb 08, 2021
SELL
$25.8 - $32.39 $3.97 Million - $4.99 Million
-153,980 Reduced 11.13%
1,229,459 $34.6 Million
Q3 2020

Nov 12, 2020
BUY
$27.5 - $39.61 $8.55 Million - $12.3 Million
311,039 Added 29.0%
1,383,439 $42.7 Million
Q2 2020

Aug 13, 2020
BUY
$36.1 - $42.56 $38.7 Million - $45.6 Million
1,072,400 New
1,072,400 $45.6 Million

Others Institutions Holding LEGN

# of Institutions
233
Shares Held
86.1M
Call Options Held
260K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.19B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email